Clearblue® Advanced Ovulation Test User Study
NCT03122951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 577
Last updated 2018-11-09
Summary
The Clearblue® Advanced Ovulation Test is designed for home use by women who are either planning or trying for a pregnancy.
The purpose of this protocol is to demonstrate that lay-users representative of the target user population are able to use the product in the intended user environment.
Conditions
- Trying to Conceive Population
Interventions
- DIAGNOSTIC_TEST
-
ovulation test use
Normal use of The Clearblue® Advanced Ovulation Test according to Information for use instructions
Sponsors & Collaborators
-
SPD Development Company Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-21
- Primary Completion
- 2017-10-27
- Completion
- 2017-10-27
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
NCT03296098 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Performance Evaluation of AMH Assay
NCT03131388 ·Status: COMPLETED
-
Sensor Technology Assessments of Reproductive Target Study
NCT06142097 ·Status: COMPLETED
-
On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility
NCT03354117 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Use of a Contraceptive Decision Aid and Patient Outcomes
NCT05973071 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771 ·Status: COMPLETED
-
Ovarian Function With ENG Implant and UPA Use
NCT04291001 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
NCT01569113 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
NCT01178125 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962 ·Status: COMPLETED
-
Quick Start of Highly Effective Contraception
NCT02076217 ·Status: COMPLETED
-
The Over The Counter Pill National Study
NCT05988983 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women
NCT02451826 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oral Contraceptive and Strength Training
NCT03374878 ·Status: COMPLETED ·Phase: NA
-
Impact of Combined Hormonal Contraceptives on UPA
NCT02577601 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
NCT00996580 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception
NCT02173808 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
NCT03662516 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
NCT00206583 ·Status: COMPLETED ·Phase: PHASE3
-
Contraceptive Efficacy Study of Ovaprene
NCT06127199 ·Status: RECRUITING ·Phase: NA
-
Contraceptive Counseling in the Postpartum Period
NCT02380781 ·Status: COMPLETED ·Phase: NA
-
A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)
NCT03230539 ·Status: UNKNOWN ·Phase: PHASE1
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
NCT06334315 ·Status: RECRUITING ·Phase: PHASE4
-
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
NCT00796133 ·Status: COMPLETED ·Phase: PHASE2